284 related articles for article (PubMed ID: 32763782)
1. A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
Tang Y; Hu Y; Wang J; Zeng Z
Int Immunopharmacol; 2020 Oct; 87():106851. PubMed ID: 32763782
[TBL] [Abstract][Full Text] [Related]
2. Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database.
Guo L; Wu Q; Ma Z; Yuan M; Zhao S
Aging (Albany NY); 2021 Jul; 13(15):19352-19374. PubMed ID: 34329197
[TBL] [Abstract][Full Text] [Related]
3. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
4. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X
J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468
[TBL] [Abstract][Full Text] [Related]
5. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
Jin K; Qiu S; Jin D; Zhou X; Zheng X; Li J; Liao X; Yang L; Wei Q
Aging (Albany NY); 2021 Jan; 13(2):1859-1871. PubMed ID: 33465047
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
Qiu H; Hu X; He C; Yu B; Li Y; Li J
Front Genet; 2020; 11():12. PubMed ID: 32117435
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
[TBL] [Abstract][Full Text] [Related]
8. Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
Tang Y; Zeng Z; Wang J; Li G; Huang C; Dong X; Feng Z
Am J Transl Res; 2020; 12(4):1184-1202. PubMed ID: 32355535
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic identification of prognostic indicators in bladder cancer.
Quan J; Zhang W; Yu C; Bai Y; Cui J; Lv J; Zhang Q
Biomark Med; 2020 Sep; 14(13):1243-1254. PubMed ID: 32749145
[No Abstract] [Full Text] [Related]
10. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
11. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
Fu Y; Sun S; Bi J; Kong C; Yin L
BMC Cancer; 2021 Jul; 21(1):810. PubMed ID: 34266411
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.
Zhang Y; Lin Y; Lv D; Wu X; Li W; Wang X; Jiang D
PeerJ; 2022; 10():e12843. PubMed ID: 35127296
[TBL] [Abstract][Full Text] [Related]
13. A new immune-related gene signature predicts the prognosis and immune escape of bladder cancer.
Liu Y; Han YS; Wang JF; Pang ZQ; Wang JS; Zhang L; He JX; Shen LK; Ji B; Ding BC; Ren MH
Cancer Biomark; 2023; 38(4):567-581. PubMed ID: 38073378
[TBL] [Abstract][Full Text] [Related]
14. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
[TBL] [Abstract][Full Text] [Related]
15. A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
Wu X; Lv D; Cai C; Zhao Z; Wang M; Chen W; Liu Y
Front Immunol; 2020; 11():590618. PubMed ID: 33391264
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
Wang L; Wang Y; Wang J; Li L; Bi J
J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
[TBL] [Abstract][Full Text] [Related]
17. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
19. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
20. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
